Dimensional Fund Advisors LP reduced its stake in LHC Group, Inc. (NASDAQ:LHCG) by 3.7% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 2,020,475 shares of the health services provider’s stock after selling 77,284 shares during the quarter. Dimensional Fund Advisors LP owned approximately 0.06% of LHC Group worth $189,682,000 at the end of the most recent quarter.
Several other hedge funds and other institutional investors have also added to or reduced their stakes in LHCG. Financial Gravity Companies Inc. purchased a new position in shares of LHC Group during the 4th quarter worth $49,000. Private Capital Group LLC grew its holdings in shares of LHC Group by 60.2% during the 4th quarter. Private Capital Group LLC now owns 897 shares of the health services provider’s stock worth $84,000 after purchasing an additional 337 shares during the period. Quantamental Technologies LLC purchased a new position in shares of LHC Group during the 4th quarter worth $182,000. CIBC Asset Management Inc purchased a new position in shares of LHC Group during the 4th quarter worth $203,000. Finally, HMS Capital Management LLC purchased a new position in shares of LHC Group during the 4th quarter worth $238,000. Institutional investors and hedge funds own 92.78% of the company’s stock.
LHCG opened at $115.06 on Friday. LHC Group, Inc. has a 12-month low of $71.81 and a 12-month high of $116.74. The company has a current ratio of 1.78, a quick ratio of 1.78 and a debt-to-equity ratio of 0.17. The stock has a market cap of $3.62 billion, a P/E ratio of 32.41, a PEG ratio of 2.00 and a beta of 0.87.
LHC Group (NASDAQ:LHCG) last posted its earnings results on Wednesday, May 8th. The health services provider reported $0.98 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.90 by $0.08. LHC Group had a return on equity of 8.40% and a net margin of 3.50%. The firm had revenue of $502.59 million for the quarter, compared to analyst estimates of $511.16 million. Equities analysts forecast that LHC Group, Inc. will post 4.2 earnings per share for the current year.
A number of research firms have recently weighed in on LHCG. Zacks Investment Research cut LHC Group from a “buy” rating to a “hold” rating in a report on Wednesday, April 10th. BidaskClub lowered LHC Group from a “strong-buy” rating to a “buy” rating in a research note on Thursday, February 28th. Barclays increased their target price on LHC Group from $95.00 to $104.00 and gave the stock an “equal weight” rating in a research note on Thursday, March 21st. Craig Hallum increased their target price on LHC Group from $93.00 to $114.00 and gave the stock a “hold” rating in a research note on Friday, March 1st. They noted that the move was a valuation call. Finally, Jefferies Financial Group increased their target price on LHC Group from $125.00 to $130.00 and gave the stock a “buy” rating in a research note on Thursday. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating and ten have issued a buy rating to the company. LHC Group has an average rating of “Buy” and a consensus target price of $114.08.
In other LHC Group news, CEO Keith G. Myers sold 11,558 shares of the stock in a transaction dated Monday, April 1st. The stock was sold at an average price of $108.83, for a total value of $1,257,857.14. Following the sale, the chief executive officer now owns 96,315 shares of the company’s stock, valued at approximately $10,481,961.45. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Keith G. Myers sold 75,000 shares of the stock in a transaction dated Friday, March 1st. The shares were sold at an average price of $108.53, for a total value of $8,139,750.00. The disclosure for this sale can be found here. In the last three months, insiders have sold 117,876 shares of company stock worth $12,762,540. 5.20% of the stock is owned by corporate insiders.
LHC Group Profile
LHC Group, Inc provides post-acute health care services to patients through its home nursing agencies, hospices and long-term acute care hospitals. The company operates through the following business segments: Home Health Services, Hospice Services, Home & Community-Based Services, Facility-Based Services and Healthcare Innovations.
Read More: Diversification in Investing
Want to see what other hedge funds are holding LHCG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for LHC Group, Inc. (NASDAQ:LHCG).